Simona King - Net Worth and Insider Trading

Simona King Net Worth

The estimated net worth of Simona King is at least $30,086 dollars as of 2024-04-29. Simona King is the CFO of Passage Bio Inc and owns about 23,994 shares of Passage Bio Inc (PASG) stock worth over $30,086. Details can be seen in Simona King's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Simona King has not made any transactions after 2023-07-28 and currently still holds the listed stock(s).

Transaction Summary of Simona King

To

Simona King Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Simona King owns 1 companies in total, including Passage Bio Inc (PASG) .

Click here to see the complete history of Simona King’s form 4 insider trades.

Insider Ownership Summary of Simona King

Ticker Comapny Transaction Date Type of Owner
PASG Passage Bio Inc 2023-07-28 Chief Financial Officer

Simona King Latest Holdings Summary

Simona King currently owns a total of 1 stock. Simona King owns 23,994 shares of Passage Bio Inc (PASG) as of July 28, 2023, with a value of $30,086.

Latest Holdings of Simona King

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PASG Passage Bio Inc 2023-07-28 23,994 1.25 30,086

Holding Weightings of Simona King


Simona King Form 4 Trading Tracker

According to the SEC Form 4 filings, Simona King has made a total of 2 transactions in Passage Bio Inc (PASG) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Passage Bio Inc is the sale of 11,453 shares on July 28, 2023, which brought Simona King around $10,079.

Insider Trading History of Simona King

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Simona King Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Simona King Ownership Network

Ownership Network List of Simona King

No Data

Ownership Network Relation of Simona King


Simona King Owned Company Details

What does Passage Bio Inc do?

Who are the key executives at Passage Bio Inc?

Simona King is the Chief Financial Officer of Passage Bio Inc. Other key executives at Passage Bio Inc include SVP & Interim CFO Kathleen Borthwick , Chief Medical Officer Mark S Forman , and 10 percent owner Orbimed Advisors Llc .

Passage Bio Inc (PASG) Insider Trades Summary

Over the past 18 months, Simona King made 2 insider transaction in Passage Bio Inc (PASG) with a net sale of 13,506. Other recent insider transactions involving Passage Bio Inc (PASG) include a net sale of 7,772 shares made by Alexandros Fotopoulos , a net purchase of 1,192,577 shares made by Orbimed Advisors Llc , and a net sale of 5,000 shares made by Sandip Kapadia .

In summary, during the past 3 months, insiders sold 3,108 shares of Passage Bio Inc (PASG) in total and bought 0 shares, with a net sale of 3,108 shares. During the past 18 months, 29,386 shares of Passage Bio Inc (PASG) were sold and 1,192,577 shares were bought by its insiders, resulting in a net purchase of 1,163,191 shares.

Passage Bio Inc (PASG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Passage Bio Inc Insider Transactions

No Available Data

Simona King Mailing Address

Above is the net worth, insider trading, and ownership report for Simona King. You might contact Simona King via mailing address: C/o Passage Bio, Inc., 2005 Market Street, 39th Floor, Philadelphia Pa 19103.

Discussions on Simona King

No discussions yet.